TY - JOUR
T1 - Knowledge and perspectives about the use of cannabis as a medicine : a mixed methods observational study in a cohort of New Zealand general practice patients
AU - Oldfield, Karen
AU - Eathorne, Allie
AU - Maijers, Ingrid
AU - Beasley, Richard
AU - Semprini, Alex
AU - Braithwaite, Irene
N1 - Publisher Copyright:
© 2020 New Zealand Medical Association. All rights reserved.
PY - 2020/9/25
Y1 - 2020/9/25
N2 - AIM: To determine what patients presenting to general practice (GP) understand about the use of cannabis as a medicine, beliefs of how this may impact their medical conditions and interactions with doctors. METHOD: An in-person survey of 134 GP patients from four GP practices throughout the North Island of New Zealand undertaken from November 2018 to October 2019. RESULTS: Fifty-five percent of the sample were female, with 40% of all participants aged 60 years plus. Ninety-one percent of participants indicated they would use a prescribed medicinal cannabis product while 45% reported they believed it may be of some benefit to their medical condition. Of those who believed it beneficial, 71% indicated they thought it useful for pain relief. Participants indicated comfort discussing medicinal cannabis use with GPs and specialists (92% respectively); however, less than 10% had done this. CONCLUSIONS: Just under half of patients surveyed believe that medicinal cannabis products may be helpful to their condition, and while the majority report willingness, few have discussed this with their GP or specialist. There is need for accessible, accurate information regarding the use of cannabis-based medicine for patients and doctors alike to guide the patient-doctor consultation and decrease barriers to open discussion.
AB - AIM: To determine what patients presenting to general practice (GP) understand about the use of cannabis as a medicine, beliefs of how this may impact their medical conditions and interactions with doctors. METHOD: An in-person survey of 134 GP patients from four GP practices throughout the North Island of New Zealand undertaken from November 2018 to October 2019. RESULTS: Fifty-five percent of the sample were female, with 40% of all participants aged 60 years plus. Ninety-one percent of participants indicated they would use a prescribed medicinal cannabis product while 45% reported they believed it may be of some benefit to their medical condition. Of those who believed it beneficial, 71% indicated they thought it useful for pain relief. Participants indicated comfort discussing medicinal cannabis use with GPs and specialists (92% respectively); however, less than 10% had done this. CONCLUSIONS: Just under half of patients surveyed believe that medicinal cannabis products may be helpful to their condition, and while the majority report willingness, few have discussed this with their GP or specialist. There is need for accessible, accurate information regarding the use of cannabis-based medicine for patients and doctors alike to guide the patient-doctor consultation and decrease barriers to open discussion.
UR - https://hdl.handle.net/1959.7/uws:66080
UR - https://www-proquest-com.ezproxy.uws.edu.au/docview/2451874546/3D7949A2D6054B25PQ/1?accountid=36155
M3 - Article
SN - 0028-8446
VL - 133
SP - 96
EP - 111
JO - New Zealand Medical Journal
JF - New Zealand Medical Journal
IS - 1522
ER -